As quality issues remain as the main reason drugs fall into shortages, the FDA unveiled a plan to incentivize drugmakers to invest in quality measures, according to a white paper.
Read the full post on Becker's Hospital Review - Healthcare News
FDA to reward drugmakers investing in quality measures
